Consolidated and Combined Condensed Statements of Earnings (Loss) and Comprehensive Income (Loss) - USD ($) shares in Millions	3 Months Ended
	Apr. 02, 2021	Mar. 27, 2020
Sales	$ 707,400,000	$ 609,200,000
Cost of sales	(395,600,000)	(346,100,000)
Gross profit	311,800,000	263,100,000
Operating costs:
Selling, general and administrative expenses	(145,700,000)	(123,100,000)
Research and development expenses	(33,200,000)	(32,900,000)
Impairment of goodwill	0	(85,300,000)
Operating profit	132,900,000	21,800,000
Non-operating expense, net:
Interest expense, net	(10,400,000)	(400,000)
Write-off of deferred financing costs	(3,200,000)	0
Other non-operating expense, net	(200,000)	(100,000)
Earnings before income taxes	119,100,000	21,300,000
Provision for income taxes	(28,100,000)	(25,500,000)
Net earnings (loss)	$ 91,000,000.0	$ (4,200,000)
Net earnings (loss) per share:
Net earnings (loss) per common share - Basic (in dollars per share)	$ 0.54	$ (0.02)
Net earnings (loss) per share - Diluted (in dollars per share)	$ 0.54	$ (0.02)
Average common stock and common equivalent shares outstanding:
Weighted average common shares outstanding used in basic earnings per share (in shares)	168.7	168.4
Weighted average common shares outstanding used in diluted earnings per share (in shares)	169.7	168.4
Other comprehensive income (loss), net of income taxes:
Net earnings (loss)	$ 91,000,000.0	$ (4,200,000)
Foreign currency translation adjustments	(15,700,000)	(46,200,000)
Other adjustments	100,000	1,700,000
Total other comprehensive loss, net of income taxes	(15,600,000)	(44,500,000)
Comprehensive income (loss)	75,400,000	(48,700,000)
Products
Sales	644,600,000	547,500,000
Cost of sales	(345,500,000)	(297,100,000)
Services
Sales	62,800,000	61,700,000
Cost of sales	$ (50,100,000)	$ (49,000,000.0)